Zacks Investment Management Repligen Corp Transaction History

Zacks Investment Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$140.68 - $188.02 $2.58 Million - $3.45 Million	-18,355 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$161.19 - $257.96 $64,314 - $102,926	399 Added 2.22%	18,355 $3.45 Million
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $26,492 - $32,578	107 Added 0.6%	17,956 $4.76 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $78,492 - $130,656	403 Added 2.31%	17,849 $5.16 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $748,239 - $996,705	4,511 Added 34.87%	17,446 $3.48 Million
Q1 2021 May 17, 2021	BUY	$180.37 - $226.26 $327,191 - $410,435	1,814 Added 16.31%	12,935 $2.51 Million
Q4 2020 Feb 16, 2021	BUY	$148.08 - $206.57 $1.05 Million - $1.47 Million	7,112 Added 177.4%	11,121 $2.13 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $73,506 - $94,962	600 Added 17.6%	4,009 $591,000
Q2 2020 Aug 14, 2020	BUY	$94.33 - $140.48 $321,570 - $478,896	3,409 New	3,409 $421,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.